Literature DB >> 19822039

Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis.

R J Lories1, D L P Baeten.   

Abstract

Rheumatoid arthritis and ankylosing spondylitis are common and severe chronic inflammatory skeletal diseases. Recognizing the differences rather than emphasizing similarities is important for a better understanding of the disease processes, the identification of specific therapeutic targets and in the long-term better treatment options for the individual patients. We discuss a number of pathophysiological differences between rheumatoid arthritis and ankylosing spondylitis by looking at the anatomical characteristics, differences and similarities in the autoimmune and autoinflammatory reactions, association with other immune mediated inflammatory diseases, structural outcome, and their potential significance for further therapeutic developments. Further research into the differences between these diseases should focus on the specific nature of the immune/inflammatory components, the role of resident cells in the joint and joint-associated tissues, the types and mechanisms of tissue remodeling and the characteristics of the articular cartilage. Better insights into their individual characteristics may lead to better therapeutic strategies, specific targets and useful biomarkers.

Entities:  

Mesh:

Year:  2009        PMID: 19822039

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  21 in total

Review 1.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

2.  Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2 -microglobulin-transgenic rat model of spondylarthritis.

Authors:  Leonie M van Duivenvoorde; Martha L Dorris; Nimman Satumtira; Melissa N van Tok; Kurt Redlich; Paul P Tak; Joel D Taurog; Dominique L Baeten
Journal:  Arthritis Rheum       Date:  2012-10

Review 3.  The IL-23-IL-17 axis in inflammatory arthritis.

Authors:  Erik Lubberts
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

Review 4.  Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?

Authors:  Rik J Lories; Kurt de Vlam
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

5.  High frequency of inflammatory back pain and other features of spondyloarthritis in patients with rheumatoid arthritis.

Authors:  Gercek Can; Dilek Solmaz; Omer Binicier; Servet Akar; Merih Birlik; Ozgul Soysal; Nurullah Akkoc; Metin Manisali; Fatos Onen
Journal:  Rheumatol Int       Date:  2012-11-06       Impact factor: 2.631

6.  Integrative structural biomechanical concepts of ankylosing spondylitis.

Authors:  Alfonse T Masi; Kalyani Nair; Brian J Andonian; Kristina M Prus; Joseph Kelly; Jose R Sanchez; Jacqueline Henderson
Journal:  Arthritis       Date:  2011-12-18

7.  Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue.

Authors:  Oliwia Rysnik; Kirsty McHugh; Leonie van Duivenvoorde; Melissa van Tok; Joel Taurog; Simon Kollnberger; Dominique Baeten; Paul Bowness
Journal:  Data Brief       Date:  2016-08-28

8.  Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.

Authors:  Anne C Bay-Jensen; Stephanie Wichuk; Inger Byrjalsen; Diana J Leeming; Nathalie Morency; Claus Christiansen; Morten A Karsdal; Walter P Maksymowych
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Serum prolidase activity in ankylosing spondylitis and rheumatoid arthritis.

Authors:  Demet Uçar; Serda Em; Mehtap Bozkurt; Pelin Oktayoglu; Hatice Kurt Yüksel; Mehmet Caglayan; Orhan Gezer; Kemal Nas
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2013-08-04

10.  Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis.

Authors:  Melissa N van Tok; Nataliya G Yeremenko; Christine A Teitsma; Barbara E Kream; Véronique L Knaup; Rik J Lories; Dominique L Baeten; Leonie M van Duivenvoorde
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.